Cancer Gene Therapy IndustryThe global cancer gene therapy industry is projected to increase at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2032, with a projected value of US$ 2 billion in 2022. According to Future Market Insights (FMI), the oncolytic virotherapy category held 49.3% of the global canc.
From 2022 to 2032, the global cancer gene therapy market is anticipated to expand at a 10.1% compound annual growth rate (CAGR) and reach US$ 2 billion in 2022. The oncolytic virotherapy segment held 49.3% of the global cancer gene therapy market in 2021, according to Future Market Insights (FMI). This market is pro.
MaxCyte Inc on Tuesday said it appointed Douglas Swirsky as its new chief financial officer, effective immediately.
The Maryland, US-based cell-engineering focused company said Swirsky previously. | March 28, 2023
ROCKVILLE, Md., March 27, 2023 MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization. | March 27, 2023
[300+ Pages Report] As per Future Market Insights’ latest revised industry analysis, the global cancer gene therapy market is projected to expand at a 10.1% CAGR over the forecast period, with the market size reaching US$ 5.3 Bn in 2032.Gene therapy is a field of medicine that aims to cure or greatly improve the tre.